Mucus clearance via expectorant effect

The "mucus clearance via expectorant effect" is a therapeutic phenomenon in which agents (typically expectorants and mucoactive drugs) promote the expulsion of mucus from the airways. These drugs work via various mechanisms—primarily by increasing the hydration and volume of airway secretions (making mucus less viscous and more easily expelled by coughing), or by breaking down mucus structure (seen with mucolytics like acetylcysteine). Common agents such as guaifenesin, hypertonic saline, and N-acetylcysteine target this physiological process in diseases characterized by mucus hypersecretion and impaired clearance (e.g., cold, bronchitis, cystic fibrosis). This target entry is not technically a molecular target and should be replaced in structured databases by the specific molecules that mediate the effect, such as "Guaifenesin," "MUC5AC/MUC5B mucin," or "CFTR protein" (for cystic fibrosis-related mucus issues).

Other names

Mucus clearanceExpectorant effectMucoactive effectChest congestion relief

Increase hydration of airway secretions (expectorants such as guaifenesin); Reduce mucus viscosity and adhesiveness (mucolytics such as acetylcysteine); Increase mucociliary transport and mucus clearance (secretomotorics); Modify mucin production/secretion (e.g., guaifenesin reduces MUC5AC and MUC5B mucin production).